ATLANTA, Georgia, October 18, 2012 /PRNewswire/ --
New material to be updated regularly as requirements in the healthcare industry evolve
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Core Measures in the Quality and Safety section of Mosby's Nursing Consult. Core Measures is in addition to content on CMS Never Events and Medication Safety already available in Nursing Consult.
The Quality and Safety section of Mosby's Nursing Consult provides nurses with resources to preserve patient safety and implement quality improvement measures. Quality and Safety information is reviewed regularly and updated as nursing evidence and practice evolve. Educators can use the information for in-service staff sessions and librarians can use the updated content to provide research support for a hospital.
Healthcare facilities are required to follow the Core Measures in order to receive Medicare & Medicaid Services (CMS) reimbursement and accreditation by The Joint Commission (TJC). Core Measures serve as a standardized set of evaluation criteria to assess care through recommended treatment, patient education, patient assessment and discharge instructions.
"Nurses play a critical role in ensuring patient safety and managing patient care," said Barbara Cullen, Vice President, Healthcare e-Learning for Elsevier. "Understanding Core Measures helps nurses understand established benchmarks and standards for treating complex conditions and diseases, reduce complication risks, prevent readmissions and integrate evidence-based nursing practices into their day-to-day activities."
CMS Never Events offers links to resources such as books, journals, guidelines, patient education, images, and tools for ten healthcare-acquired conditions to assist nurses in preventing situations such as conducting surgery on the wrong patient or at an incorrect site.
Medication Safety provides resources to help nurses minimize the risk of medication errors and improve medication safety. Information is included on pediatric populations and specific classes of drugs to improve patient care.
A webinar with free continuing education credit will be held on Friday, October 19 at 2:00 pm ET. This detailed webinar will cover why Core Measures were created and illustrate the importance of Core Measures in ensuring quality of patient care. Register online for this webinar.
About Elsevier Clinical Decision Support
Elsevier Clinical Decision Support (http://www.clinicaldecisionsupport.com), a division of Elsevier, the global leader in medical and health information, provides world class information and point-of-care technology solutions that optimize decisions and actions to improve the overall quality, safety and cost-effectiveness of care. The business delivers on this promise through actionable clinical content, care planning and documentation, drug reference and decision support, learning and performance management, and data mining and outcomes analytics solutions for provider, pharmacy and payer organizations.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations